As of June 06, 2026, Xeris Biopharma Holdings's top three insider holders are Paul R Edick (Director, 3.79Mn shares), John Patrick Jr Shannon (Director, 2.94Mn shares), Kevin Mcculloch (Officer, 1.78Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Jeffrey W Sherman | - | 219,188 | 0 | 29 Aug, 2025 |
| Marla Persky | - | 142,000 | 0 | 12 Sep, 2025 |
| John Johnson | - | 698,083 | 0 | 19 Dec, 2025 |
| Garheng Kong | - | 214,144 | 0 | 04 Jun, 2025 |
| John P. Schmid | - | 113,159 | 0 | 05 Jun, 2024 |
| Paul R Edick | - | 3,788,064 | 0 | 31 Jan, 2024 |
| John Patrick Jr Shannon | - | 2,935,578 | 0 | 02 Feb, 2026 |
| Barbara-Jean Anne Bormann-Kennedy | - | 142,500 | 0 | 15 Dec, 2025 |
| Beth Hecht | - | 1,209,840 | 0 | 03 Apr, 2026 |
| Dawn Halkuff | - | 115,000 | 0 | 13 Aug, 2025 |
| Kenneth Erland Johnson | - | 320,446 | 0 | 03 Feb, 2025 |
| Steven Prestrelski | Chief Scientific Officer | 719,780 | 0 | 01 Feb, 2023 |
| Steven Pieper | - | 1,408,940 | 0 | 05 Mar, 2026 |
| James Aloysius Brady | - | 89,166 | 0 | 01 Apr, 2026 |
| Ricki Louise Fairley | - | 135,000 | 0 | 05 Jun, 2024 |
| Kevin Mcculloch | - | 1,777,725 | 0 | 16 Mar, 2026 |
| Anh Tu Nguyen | - | 395,023 | 0 | 25 Feb, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 01 Apr, 2026 | Beth Hecht | Common Stock | D | 16,667 | $5.99 | 1,209,840 | D | S |
| 30 Mar, 2026 | James Aloysius Brady | Common Stock | D | 10,834 | $5.54 | 89,166 | D | S |
| 12 Mar, 2026 | Kevin Mcculloch | Common Stock | A | 48,894 | $4.09 | 1,777,721 | D | M |
| 12 Mar, 2026 | Kevin Mcculloch | Common Stock | A | 4 | $3.94 | 1,777,725 | D | M |
| 12 Mar, 2026 | Kevin Mcculloch | Stock Option (Right to Buy) | D | 48,894 | $4.09 | 43,773 | D | M |
| 12 Mar, 2026 | Kevin Mcculloch | Stock Option (Right to Buy) | D | 4 | $3.94 | 79,996 | D | M |
| 05 Mar, 2026 | Steven Pieper | Common Stock | A | 27,891 | $4.09 | 1,394,904 | D | M |
| 05 Mar, 2026 | Steven Pieper | Common Stock | A | 14,036 | $5.93 | 1,408,940 | D | M |
| 05 Mar, 2026 | Steven Pieper | Stock Option (Right to Buy) | D | 27,891 | $0.00 | 0 | D | M |
| 05 Mar, 2026 | Steven Pieper | Stock Option (Right to Buy) | D | 14,036 | $0.00 | 0 | D | M |
| 02 Mar, 2026 | Beth Hecht | Common Stock | D | 16,567 | $6.24 | 1,226,607 | D | S |
| 02 Mar, 2026 | Beth Hecht | Common Stock | D | 100 | $7.06 | 1,226,507 | D | S |
| 24 Feb, 2026 | Anh Tu Nguyen | Common Stock | D | 29,300 | $6.88 | 395,023 | D | F |
| 30 Jan, 2026 | Kevin Mcculloch | Common Stock | A | 168,463 | $0.00 | 1,853,889 | D | A |
| 30 Jan, 2026 | Beth Hecht | Common Stock | A | 121,293 | $0.00 | 1,429,396 | D | A |
| 30 Jan, 2026 | John Patrick Jr Shannon | Common Stock | A | 478,436 | $0.00 | 3,276,083 | D | A |
| 30 Jan, 2026 | Steven Pieper | Common Stock | A | 154,986 | $0.00 | 1,572,547 | D | A |
| 30 Jan, 2026 | Anh Tu Nguyen | Common Stock | A | 121,293 | $0.00 | 424,323 | D | A |
| 31 Jan, 2026 | Steven Pieper | Common Stock | D | 111,765 | $7.36 | 1,460,782 | D | F |
| 31 Jan, 2026 | Beth Hecht | Common Stock | D | 98,375 | $7.36 | 1,331,021 | D | F |